YH12852 clinical trials
Also written YH12852.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses YH12852 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- YH12852
- 2
Studies by the year they started
4 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Yuhan Corporation (3) · Seoul National University Hospital (1)
Studies
Open first, then newest update. How each study uses YH12852 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional DyspepsiaTerminatedPhase 2Yuhan CorporationNCT02567578Written as YH12852 0.1 mgHow we know
- Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852CompletedPhase 1Seoul National University HospitalNCT03381703Written as YH12852How we know
- Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional ConstipationCompletedPhase 1/2Yuhan CorporationNCT02538367Written as YH12852 IR 0.05mgHow we know
- Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male SubjectsCompletedPhase 1Yuhan CorporationNCT01870674Written as YH12852How we know
Codes
What other systems call YH12852 · ClinicalTrials.gg INT000956
- MeSH (NLM) C000627745YH12852One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000627745 | YH12852 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.